Glucuronolactone Market Expected to Reach $617.3 Million by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Glucuronolactone Market," The glucuronolactone market size was valued at $380.3 million in 2022, and is estimated to reach $617.3 million by 2032, growing at a CAGR of 5.2% from 2023 to 2032.

The organic metabolite glucuronolactone, also known as "D-glucuronolactone" or "D-glucuronic acid," is present in the body. This odorless solid white substance is a significant element in energy drinks and stimulants like Red Bull. Glucuronolactone is a naturally occurring chemical compound found in connective tissues such as animal and human cartilage, ligaments, and tendons. The substance is also generated from plant gums and is classified as a glucuronic acid lactone.

Glucuronolactone is used as one of the main ingredients in various energy drinks and supplements owing to its various benefits. Integration of IoT, ML, and AI technology in medical processes and equipment drives market development. These technologies have brought about significant improvements in various aspects of healthcare, including patient care, diagnostics, treatment, and operational efficiency. IoT, ML, and AI have contributed to the growth of the medical industry by aiding remote patient monitoring, personalized medicine, data security and privacy. Furthermore, increased chronic disease occurrences, as well as a growing geriatric population, are contributing to overall market growth. The widespread use of glucuronolactone in the food and beverage industries, such as in curing, pickling, and leavening agent, is expected to drive market expansion. Furthermore, the widespread use of home care settings, point-of-care diagnostics, and increased awareness of glucuronolactone in prescription medications for treating bone disease, hepatitis, and collagen disease are predicted to drive Glucuronolactone Market Opportunities expansion during the projection period.

However, glucuronolactone-based drugs may cause anxiety, insomnia, muscle twitching, or an increase in heart rate, which can be dangerous to people with high blood pressure. The safest amount of glucuronolactone supplementation is 500 to 600 mg per day. When used in large quantities, it might produce headaches, stomach cramps, and irritation. Furthermore, it might cause aggressive behavior and insomnia, which are expected to hinder growth of Glucuronolactone market forecast .

The glucuronolactone industry is expanding due to the increasing investments in the pharmaceutical industry. This can be due to the growing use of glucuronolactone in the manufacture of medicines, where it is used as a stabilizer and for other purposes. Additionally, the overall market is expanding as a result of the increased prevalence of chronic diseases and the rising elderly population. Additionally, it is anticipated that the widespread use of glucuronolactone in the food and beverage industry, such as in curing, pickling, and leavening agent, will support market expansion. Furthermore, it is predicted that the demand for glucuronolactone will expand throughout the forecast period due to rising health consciousness and increased interest in enhancing physical fitness. Additionally, Hubei Yitai Pharmaceutical Co., Ltd offers glucuronolactone used as a food additive, which is widely used in health foods and functional beverages. The product regulates immune function, anti-aging, moistening skin, improving oxygen to the brain, and helps in recovering from fatigue. All these factors are predicted to create an excellent opportunity for glucuronolactone market growth during the forecast period.

The glucuronolactone market share is segmented on the basis of type, application, end use, and region. By type, it is classified into powder, liquid, and tablet & capsule. By application, it is classified into preservatives, antioxidants, processing aids & additives, energy supplements, and others. By end user. It is classified into food & beverages, pharmaceuticals, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in the glucuronolactone market analysis report include Anhui Fubore Pharmaceutical & Chemical Co.Ltd., Hubei Yitai Pharmaceutical Co.Ltd., Shandong Fuyuan Bio-Tech CO.LTD., Shandong Baisheng Biotechnology Co., Ltd., Functional Food chem International Corporation, Shaoxing Marina Biotechnology Co.Ltd., Merck Millipore Corporation, Jungbunzlauer, Shandong Xinhong Pharmaceutical Co., Ltd., and Roquette Frères.

The report offers a comprehensive analysis of the global glucuronolactone market trends by thoroughly studying different aspects of the market including major segments, market statistics, market dynamics, regional market outlook, investment opportunities, and top players working towards the growth of the market. The report also highlights on the present scenario and upcoming trends & developments that are contributing toward the growth of the market. Moreover, restraints and challenges that hold power to obstruct the market growth are also profiled in the report along with the Porter’s five forces analysis of the market to elucidate factors such as competitive landscape, bargaining power of buyers and suppliers, threats of new players, and emergence of substitutes in the market.

Impact of COVID-19 on the Global Glucuronolactone Industry

• Initially, COVID-19 led to disruptions in supply chains, manufacturing, and distribution, which led to challenges in sourcing raw materials and maintaining production levels. Lockdowns and reduced economic activity also impacted consumer spending on dietary supplements and related products, affecting the demand.
• The pandemic underscored the importance of health and immunity, interest in supplements like glucuronolactone, known for potential cognitive and energy-enhancing benefits, grew. The shift towards remote work and focus on personal well-being contributed to this trend. Manufacturers adapted by emphasizing online sales channels and promoting the immune-boosting aspects of their products, aiding industry recovery.
• In the post-COVID-19 pandemic, the glucuronolactone market is expected to undergo several changes. With an increased focus on health and well-being, there could be a surge in demand for dietary supplements and functional ingredients like glucuronolactone, as consumers seek products that support their immune systems and overall health.

Key Findings of the Study

• Based on type, the liquid sub-segment emerged as the global leader in 2022 and powder sub-segment is anticipated to be the fastest growing sub-segment during the forecast period.
• Based on application, the antioxidants sub-segment emerged as the global leader in 2022 and energy supplements sub-segment is predicted to show the fastest growth in the upcoming years.
• Based on end user, the pharmaceuticals sub-segment emerged as the global leader in 2022 and food & beverages sub-segment is predicted to show the fastest growth in the upcoming years.
• Based on region, the North America market registered the highest market share in 2022 and Asia-Pacific is predicted to show the fastest growth in the upcoming years.